Pharmaceuticals and Hospitals

In an article published in African Business on 30th December 2014, Nell Ford stated the following bitter truth: “Africa carries around 24% of the global disease and illness burden but its pharmaceutical industry is worth less than 1% of this $857bn global industry.” Speaking in the same vein Feng Zhao of the African Development Bank observed that producing drugs locally could bring many benefits for the continent. “If you look at the pharmaceutical sector now, the size is very small compared to the global overall size. Africa is now less than 1 percent of the global share,” noted Zhao. “It has great potential to grow, the average growth rate is expected to be more than 10 percent.”

African Mega Projects Investors (AMPI) considers the pharmaceutical industry a great niche of opportunity not only for business but also for providing adequate answers to the Africans’ health issues. We are working hand in hand with African governments and partners to build world-class hospitals in the continent and make quality and affordable drugs available to patients.